Depending on Epitope Profile of COVID-19 mRNA Vaccine Recipients: Are They More Efficient Against the Arising Viral Variants? An Opinion Article

Front Med (Lausanne). 2022 Jun 20:9:903876. doi: 10.3389/fmed.2022.903876. eCollection 2022.

¹ Department of Protein Research, Genetic Engineering and Biotechnology Research Institute (GEBRI), City of Scientific Research and Technological Applications (SRTA-City), Alexandria, Egypt.

No abstract available

Keywords: COVID-19; RBD; epitopes; mRNA vaccine; neutralizing antibodies; spike; subunit vaccine; viral variant.